Současné možnosti léčby androgenetické alopecie u mužů a žen

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F05%3A00002029" target="_blank" >RIV/61989592:15110/05:00002029 - isvavai.cz</a>

Výsledek na webu

—

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Current methods of treatment in male and female androgenetic alopecia

Popis výsledku v původním jazyce

Androgenetic alopecia (AGA) is the most common form of alopecia affecting millions of men and women. AGA is an androgen hormone dependent process involving continuous miniaturization of sensitive hair follicles in both men and women, who are geneticallypredisposed. It has been reported to be a polygenic trait that is believed to involve several genes for both sexes. Hair loss in women is usually much less severe than in men, newertheless in affected women AGA causes serious psychological problems and its etiopathogenesis, especially in women, is not yet fully understood. However, experimental and clinical advances elucidate some pathogenetic steps leading to AGA. Currently most promissing approaches to the treatment of baldness in men are drug therapies, such as topical minoxidil and finasteride administered systemically. AGA in women can be treated with topical minoxidil, too, but in contrast to men antiandrogens administered systemically are frequently used.

Název v anglickém jazyce

Current methods of treatment in male and female androgenetic alopecia

Popis výsledku anglicky

Androgenetic alopecia (AGA) is the most common form of alopecia affecting millions of men and women. AGA is an androgen hormone dependent process involving continuous miniaturization of sensitive hair follicles in both men and women, who are geneticallypredisposed. It has been reported to be a polygenic trait that is believed to involve several genes for both sexes. Hair loss in women is usually much less severe than in men, newertheless in affected women AGA causes serious psychological problems and its etiopathogenesis, especially in women, is not yet fully understood. However, experimental and clinical advances elucidate some pathogenetic steps leading to AGA. Currently most promissing approaches to the treatment of baldness in men are drug therapies, such as topical minoxidil and finasteride administered systemically. AGA in women can be treated with topical minoxidil, too, but in contrast to men antiandrogens administered systemically are frequently used.

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FO - Dermatovenerologie

OECD FORD obor

—

Projekt

<a href="/cs/project/NR8386" target="_blank" >NR8386: Exprese molekulárních znaků regulujících vývoj a diferenciaci vlasového folikulu u trichogenních nádorů</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2005

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Kosmetische Medizin: cosmetic medicine

ISSN

1430-4031

e-ISSN

—

Svazek periodika

26

Číslo periodika v rámci svazku

3

Stát vydavatele periodika

DE - Spolková republika Německo

Počet stran výsledku

5

Strana od-do

118-122

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—